Literature DB >> 33358091

A systematic review of multifocal and multicentric glioblastoma.

Yao Li1, Zuo-Xin Zhang1, Guo-Hao Huang1, Yan Xiang1, Lin Yang1, Yu-Chun Pei1, Wei Yang1, Sheng-Qing Lv2.   

Abstract

Multiple glioblastoma multiforme (GBM) is classified as multifocal and multicentric GBM according to whether there is communication between the lesions. Multiple GBM is more genetically heterogeneous, aggressive and resistant to chemoradiotherapy than unifocal GBM, and has a worse prognosis. There is no international consensus on the treatment of multiple GBM. This review discusses some paradigms of multiple GBM and focuses on the heterogeneity spread pathway, imaging diagnosis, pathology, molecular characterization and prognosis of multifocal and multicentric GBM. Several promising therapeutic methods of multiple GBM are also recommended.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glioblastoma; Glioma; Multicentric; Multifocal

Year:  2021        PMID: 33358091     DOI: 10.1016/j.jocn.2020.11.025

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

1.  RRM2 Mediates the Anti-Tumor Effect of the Natural Product Pectolinarigenin on Glioblastoma Through Promoting CDK1 Protein Degradation by Increasing Autophagic Flux.

Authors:  Haiping Jiang; Dongzhi Zhang; Karpov Denis Aleksandrovich; Junyi Ye; Lixiang Wang; Xiaofeng Chen; Ming Gao; Xinzhuang Wang; Tao Yan; He Yang; Enzhou Lu; Wenwu Liu; Cheng Zhang; Jianing Wu; Penglei Yao; Zhenying Sun; Xuan Rong; Sokhatskii Andrei Timofeevich; Safin Shamil Mahmutovich; Zhixing Zheng; Xin Chen; Shiguang Zhao
Journal:  Front Oncol       Date:  2022-05-11       Impact factor: 5.738

Review 2.  Updates in IDH-Wildtype Glioblastoma.

Authors:  Mary Jane Lim-Fat; James R Perry; Jawad M Melhem; Jay Detsky
Journal:  Neurotherapeutics       Date:  2022-05-31       Impact factor: 6.088

Review 3.  Newly Diagnosed Multifocal GBM: A Monocentric Experience and Literature Review.

Authors:  Valentina Baro; Giulia Cerretti; Michela Todoverto; Alessandro Della Puppa; Franco Chioffi; Francesco Volpin; Francesco Causin; Fabio Busato; Pasquale Fiduccia; Andrea Landi; Domenico d'Avella; Vittorina Zagonel; Luca Denaro; Giuseppe Lombardi
Journal:  Curr Oncol       Date:  2022-05-11       Impact factor: 3.109

4.  Deep Learning With Data Enhancement for the Differentiation of Solitary and Multiple Cerebral Glioblastoma, Lymphoma, and Tumefactive Demyelinating Lesion.

Authors:  Yu Zhang; Kewei Liang; Jiaqi He; He Ma; Hongyan Chen; Fei Zheng; Lingling Zhang; Xinsheng Wang; Xibo Ma; Xuzhu Chen
Journal:  Front Oncol       Date:  2021-08-18       Impact factor: 6.244

5.  T2/FLAIR Abnormity Could be the Sign of Glioblastoma Dissemination.

Authors:  Mingxiao Li; Wei Huang; Hongyan Chen; Haihui Jiang; Chuanwei Yang; Shaoping Shen; Yong Cui; Gehong Dong; Xiaohui Ren; Song Lin
Journal:  Front Neurol       Date:  2022-02-02       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.